Bokf Na Sells 5,760 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bokf Na lessened its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 59,205 shares of the healthcare conglomerate’s stock after selling 5,760 shares during the quarter. Bokf Na’s holdings in UnitedHealth Group were worth $30,827,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. NewSquare Capital LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter worth approximately $28,000. AlphaMark Advisors LLC purchased a new stake in UnitedHealth Group during the fourth quarter valued at about $30,000. Finally, Aster Capital Management DIFC Ltd purchased a new position in UnitedHealth Group in the 4th quarter worth approximately $30,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock opened at $404.81 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The stock has a market cap of $368.47 billion, a price-to-earnings ratio of 26.12, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1 year low of $393.11 and a 1 year high of $630.73. The firm’s 50-day moving average is $494.68 and its 200 day moving average is $527.03.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the previous year, the firm earned $6.91 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a yield of 2.08%. The ex-dividend date was Monday, March 10th. UnitedHealth Group’s dividend payout ratio is currently 35.18%.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Oppenheimer decreased their target price on shares of UnitedHealth Group from $640.00 to $600.00 and set an “outperform” rating on the stock in a research note on Monday, April 21st. StockNews.com raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Barclays reduced their price target on UnitedHealth Group from $642.00 to $560.00 and set an “overweight” rating on the stock in a report on Monday, April 21st. Morgan Stanley reduced their target price on UnitedHealth Group from $664.00 to $563.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 22nd. Finally, Robert W. Baird cut their price target on shares of UnitedHealth Group from $640.00 to $510.00 and set an “outperform” rating on the stock in a report on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.